Positive autoregulation of GDNF levels in the ventral tegmental area mediates long-lasting inhibition of excessive alcohol consumption

被引:33
作者
Barak, S. [1 ]
Ahmadiantehrani, S. [1 ,3 ]
Kharazia, V. [1 ]
Ron, D. [1 ,2 ,3 ]
机构
[1] Univ Calif San Francisco, Ernest Gallo Res Ctr, Emeryville, CA USA
[2] Univ Calif San Francisco, Ernest Gallo Res Ctr, Dept Neurol, San Francisco, CA 94608 USA
[3] Univ Calif San Francisco, Grad Program Pharmaceut Sci & Pharmacogen, San Francisco, CA 94608 USA
基金
美国国家卫生研究院;
关键词
addiction; alcohol; GDNF; growth factors; ventral tegmental area; ANTI-ADDICTION DRUG; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; C-RET; NERVOUS-SYSTEM; RECEPTOR-ALPHA; MESSENGER-RNAS; GENE-THERAPY; RAT-BRAIN; EXPRESSION;
D O I
10.1038/tp.2011.57
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Glial cell line-derived neurotrophic factor (GDNF) is an essential growth factor for the survival and maintenance of the midbrain dopaminergic (DA-ergic) neurons. Activation of the GDNF pathway in the ventral tegmental area (VTA), where the GDNF receptors are expressed, produces a long-lasting suppression of excessive alcohol consumption in rats. Previous studies conducted in the DA-ergic-like cells, SHSY5Y, revealed that GDNF positively regulates its own expression, leading to a long-lasting activation of the GDNF signaling pathway. Here we determined whether GDNF activates a positive autoregulatory feedback loop in vivo within the VTA, and if so, whether this mechanism underlies the long-lasting suppressive effects of the growth factor on excessive alcohol consumption. We found that a single infusion of recombinant GDNF (rGDNF; 10 mu g) into the VTA induces a long-lasting local increase in GDNF mRNA and protein levels, which depends upon de novo transcription and translation of the polypeptide. Importantly, we report that the GDNF-mediated positive autoregulatory feedback loop accounts for the long-lasting inhibitory actions of GDNF in the VTA on excessive alcohol consumption. Specifically, the long-lasting suppressive effects of a single rGDNF infusion into the VTA on excessive alcohol consumption were prevented when protein synthesis was inhibited, as well as when the upregulation of GDNF expression was prevented using short hairpin RNA to focally knock down GDNF mRNA in the VTA. Our results could have implications for the development of long-lasting treatments for disorders in which GDNF has a beneficial role, including drug addiction, chronic stress and Parkinson's disease. Translational Psychiatry (2011) 1, e60; doi:10.1038/tp.2011.57; published online 13 December 2011
引用
收藏
页码:e60 / e60
页数:9
相关论文
共 50 条
[31]   Persistent disruption of an established morphine conditioned place preference [J].
Milekic, MH ;
Brown, SD ;
Castellini, C ;
Alberini, CM .
JOURNAL OF NEUROSCIENCE, 2006, 26 (11) :3010-3020
[32]   Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray [J].
Mundel, S ;
Grünblatt, E ;
Maor, G ;
Youdim, MBH .
NEUROCHEMICAL RESEARCH, 2002, 27 (10) :1231-1243
[33]  
OBRIG TG, 1971, J BIOL CHEM, V246, P174
[34]   Neurotrophins induce short-term and long-term changes of cortical neurotrophin expression [J].
Patz, S ;
Wahle, P .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 20 (03) :701-708
[35]   Neuronal GDNF expression in the adult rat nervous system identified by in situ hybridization [J].
Pochon, NAM ;
Menoud, A ;
Tseng, JL ;
Zurn, AD ;
Aebischer, P .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1997, 9 (03) :463-471
[36]   Brain-derived neurotrophic factor (BDNF) induces dendritic targeting of BDNF and tyrosine kinase B mRNAs in hippocampal neurons through a phosphatidylinositol-3 kinase-dependent pathway [J].
Righi, M ;
Tongiorgi, E ;
Cattaneo, A .
JOURNAL OF NEUROSCIENCE, 2000, 20 (09) :3165-3174
[37]   Driving GDNF expression: The green and the red traffic lights [J].
Saavedra, Ana ;
Baltazar, Graca ;
Duarte, Emilia P. .
PROGRESS IN NEUROBIOLOGY, 2008, 86 (03) :186-215
[38]   Novel functions and signalling pathways for GDNF [J].
Sariola, H ;
Saarma, M .
JOURNAL OF CELL SCIENCE, 2003, 116 (19) :3855-3862
[39]   Crossroads in GDNF therapy for Parkinson's disease [J].
Sherer, TB ;
Fiske, BK ;
Svendsen, CN ;
Lang, AE ;
Langston, JW .
MOVEMENT DISORDERS, 2006, 21 (02) :136-141
[40]   INHIBITION OF PROTEIN SYNTHESIS IN VITRO BY CYCLOHEXIMIDE [J].
SIEGEL, MR ;
SISLER, HD .
NATURE, 1963, 200 (490) :675-&